Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 291 Carcinoma, Non-Small-Cell Lung 206 Prostatic Neoplasms 158 Lung Neoplasms 93 Stomach Neoplasms 69 Neoplasms 69 Head and Neck Neoplasms 60 Squamous Cell Carcinoma of Head and Neck 56 Neoplasm Metastasis 50 Esophageal Neoplasms 49 Ovarian Neoplasms 39 Pancreatic Neoplasms 26 Sarcoma 23 Carcinoma, Ovarian Epithelial 20 Urinary Bladder Neoplasms 19 Unspecified Adult Solid Tumor, Protocol Specific 19 Breast Neoplasms, Male 17 Adenocarcinoma Of Esophagus 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 16 Esophageal Squamous Cell Carcinoma 16 Adenocarcinoma of Lung 16 Fallopian Tube Neoplasms 14 Carcinoma, Squamous Cell 14 Adenocarcinoma 12 Melanoma 11 Inflammatory Breast Neoplasms 11 Uterine Cervical Neoplasms 9 Triple Negative Breast Neoplasms 9 Salivary Gland Neoplasms 8 Endometrial Neoplasms 8

Interventions

Fluorouracil 7 Radiotherapy 6 Cisplatin 6 Mitomycin 3 Cetuximab 2 toripalimab 1 atezolizumab 1 Vaccines 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Neoadjuvant Therapy 1 Mitomycins 1 Docetaxel 1 Capecitabine 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Anal Canal Carcinoma × Docetaxel × Clear all

NCT02402842 2022-05-16

Epitopes-HPV02

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed

Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡